NextPlat (NXPL) Times Interest Earned (2015 - 2025)
NextPlat's (NXPL) quarterly Times Interest Earned came in at 217.47 in Q4 2025, down 80.59% year-over-year from 1120.51 in Q4 2024, and down 53.07% quarter-over-quarter from 142.07 in Q3 2025.
Powered by 
Analysis
NextPlat (NXPL) Times Interest Earned (2015 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Times Interest Earned for 11 consecutive years, with 217.47 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Times Interest Earned fell 80.59% year-over-year to 217.47 in Q4 2025; TTM through Dec 2025 was 149.98, a 47.24% increase from a year earlier, with the FY2025 full-year figure at 140.62, up 50.53% from the prior year.
- Times Interest Earned was 217.47 for Q4 2025 at NextPlat, down from 142.07 in the prior quarter.
- Over five years, Times Interest Earned peaked at 0.57 in Q1 2021 and troughed at 1067.36 in Q4 2021.
- A 5-year average of 332.19 and a median of 247.87 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 126723.33% in 2021 and soared 81.73% in 2024, its largest moves.
- Over 5 years, Times Interest Earned stood at 1067.36 in 2021, then soared by 70.04% to 319.75 in 2022, then plunged by 106.09% to 658.96 in 2023, then soared by 81.73% to 120.42 in 2024, then sank by 80.59% to 217.47 in 2025.
- The last three Times Interest Earned figures came in at 217.47 (Q4 2025), 142.07 (Q3 2025), and 121.93 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -3.02 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 1.87 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.79 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 579.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -217.47 |
| Sep 30, 2025 | -142.07 |
| Jun 30, 2025 | -121.93 |
| Mar 31, 2025 | -115.78 |
| Dec 31, 2024 | -120.42 |
| Sep 30, 2024 | -363.59 |
| Jun 30, 2024 | -573.47 |
| Mar 31, 2024 | -87.71 |
| Dec 31, 2023 | -658.96 |
| Sep 30, 2023 | -75.59 |
| Jun 30, 2023 | -671.00 |
| Mar 31, 2023 | -247.60 |
| Dec 31, 2022 | -319.75 |
| Sep 30, 2022 | -248.13 |
| Jun 30, 2022 | -416.53 |
| Mar 31, 2022 | -257.36 |
| Dec 31, 2021 | -1,067.36 |
| Sep 30, 2021 | -937.88 |
| Jun 30, 2021 | -0.58 |
| Mar 31, 2021 | -0.57 |